This public workshop provided a venue for stakeholders to (1) examine ways to advance regulatory science for MCM development and regulatory evaluation; (2) identify scientific opportunities to improve ...
DURHAM, N.C., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), ...
RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development
Opaganib awarded a further $1.7 million in U.S. Government funding for development as a medical countermeasure for gastrointestinal acute radiation syndrome (ARS) The Small Business Innovation ...
The Biomedical Advanced Research and Development Authority within the Department of Health and Human Services is soliciting comments on a draft solicitation for the second iteration of a program meant ...
DURHAM, N.C., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results